Koch Institute investigators have been pioneers in the use of animal models to study the molecular basis underlying the genesis and progression of cancer and are at the forefront of using animal modeling to address cancer detection and treatment. The Histology Core Facility has an outstanding histotechnology staff that provides cutting-edge histological expertise to all cancer researchers utilizing in vivo models. This expertise includes all aspects of histological analysis, from processing and sectioning to specialized staining and pathologic examination of tissue samples. Investigator training, from slide preparation to analysis, is another core component of this Core's mission. In addition, the Center continues to benefit from intellectual insight provided by veterinary pathologist, Dr. Roderick Bronson, an internationally recognized expert in mouse pathology. Dr. Bronson has made invaluable contributions to the characterization of developmental and tumor phenotypes, and has trained numerous Kl students, fellows and staff in histopathology. This has fostered exchange of intellectual expertise between Core staff and Center member laboratories and has played a significant role in strengthening the integrative nature of the Kl research program. Centralizing histological analyses under the auspices of the shared Histology Core allows us to capitalize on economies of scale and thereby provide cancer researchers a comprehensive and robust range of services. Over the current funding period, there has been a significant increase in the demand for these services, reflecting the broadening use of animal models by Center members. The Histology Core has responded to this need by increasing staff size and acquiring new instrumentation, which have enabled significantly greater and more efficient sample throughput. Accordingly, Core output in the immediate past funding year was substantially increased in all service categories in comparison to the last competing renewal. Based on continually increasing demand, additional service enhancements are planned for the requested funding period, which will allow us to expand both the usage and the Core Facility offerings without affecting the turnaround time for services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-42
Application #
8466733
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
42
Fiscal Year
2013
Total Cost
$200,328
Indirect Cost
$88,838
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Lannagan, Tamsin R M; Lee, Young K; Wang, Tongtong et al. (2018) Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut :
Filbin, Mariella G; Tirosh, Itay; Hovestadt, Volker et al. (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331-335
Roper, Jatin; Tammela, Tuomas; Akkad, Adam et al. (2018) Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Nat Protoc 13:217-234
Suzuki, Hiroshi I; Spengler, Ryan M; Grigelioniene, Giedre et al. (2018) Deconvolution of seed and RNA-binding protein crosstalk in RNAi-based functional genomics. Nat Genet 50:657-661
McKenney, Anna Sophia; Lau, Allison N; Somasundara, Amritha Varshini Hanasoge et al. (2018) JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. J Clin Invest 128:789-804
Richardson, Christopher E R; Cunden, Lisa S; Butty, Vincent L et al. (2018) A Method for Selective Depletion of Zn(II) Ions from Complex Biological Media and Evaluation of Cellular Consequences of Zn(II) Deficiency. J Am Chem Soc 140:2413-2416
Choudhury, Atish D; Werner, Lillian; Francini, Edoardo et al. (2018) Tumor fraction in cell-free DNA as a biomarker in prostate cancer. JCI Insight 3:
Chen, Pan-Yu; Muzumdar, Mandar Deepak; Dorans, Kimberly Judith et al. (2018) Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells. Cancer Res 78:985-1002
Wong, Madeline Y; Chen, Kenny; Antonopoulos, Aristotelis et al. (2018) XBP1s activation can globally remodel N-glycan structure distribution patterns. Proc Natl Acad Sci U S A 115:E10089-E10098
Viswanathan, Srinivas R; Nogueira, Marina F; Buss, Colin G et al. (2018) Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer. Nat Genet 50:937-943

Showing the most recent 10 out of 904 publications